Suzanne Cuda News Today

Drugs like Ozempic don't work for everyone, and you need to get them through a licensed physician.

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,...

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,...

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.

A tiny but quickly increasing proportion of American teenagers started taking Novo Nordisks NONOb.CO weight-loss medication Wegovy last year which is being considered a potent new tool to combat...

In March last year, Billy Small Jr. of Oakland, California, was on the cusp of developing type 2 diabetes, weighing in at 385 pounds (176 kilograms) - twice that of the average boy his age.

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address...

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisks weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.

By Robin Respaut and Chad Terhune (Reuters) - A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according ...